ClinicalTrials.govpublic full text
A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)
healthy volunteers, anle138b (tev-56286), alpha-synuclein, oligomer modulator, multiple system atrophy, parkinson disease, alzheimer disease, neurodegenerative diseases, tauopathies, amyloid, drug-drug interaction, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 915066
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.